ATE408025T1 - Biallelische marker die im zusammenhang stehen mit medikamentenmetabolismus beteiligten genen - Google Patents

Biallelische marker die im zusammenhang stehen mit medikamentenmetabolismus beteiligten genen

Info

Publication number
ATE408025T1
ATE408025T1 AT00912847T AT00912847T ATE408025T1 AT E408025 T1 ATE408025 T1 AT E408025T1 AT 00912847 T AT00912847 T AT 00912847T AT 00912847 T AT00912847 T AT 00912847T AT E408025 T1 ATE408025 T1 AT E408025T1
Authority
AT
Austria
Prior art keywords
biallelic markers
genes involved
biallelic
drug metabolism
markers related
Prior art date
Application number
AT00912847T
Other languages
English (en)
Inventor
Marta Blumenfeld
Lydie Bougueleret
Ilya Chumakov
Annick Cohen-Akenine
Original Assignee
Serono Genetics Inst Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Genetics Inst Sa filed Critical Serono Genetics Inst Sa
Application granted granted Critical
Publication of ATE408025T1 publication Critical patent/ATE408025T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/142—Toxicological screening, e.g. expression profiles which identify toxicity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT00912847T 1999-03-25 2000-03-24 Biallelische marker die im zusammenhang stehen mit medikamentenmetabolismus beteiligten genen ATE408025T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12626999P 1999-03-25 1999-03-25
US13196199P 1999-04-30 1999-04-30

Publications (1)

Publication Number Publication Date
ATE408025T1 true ATE408025T1 (de) 2008-09-15

Family

ID=26824461

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00912847T ATE408025T1 (de) 1999-03-25 2000-03-24 Biallelische marker die im zusammenhang stehen mit medikamentenmetabolismus beteiligten genen

Country Status (6)

Country Link
EP (1) EP1218537B1 (de)
AT (1) ATE408025T1 (de)
AU (1) AU784761B2 (de)
CA (1) CA2363551A1 (de)
DE (1) DE60040231D1 (de)
WO (1) WO2000058508A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7659102B2 (en) 2001-02-21 2010-02-09 Verenium Corporation Amylases, nucleic acids encoding them and methods for making and using them
ATE510023T1 (de) 2001-02-21 2011-06-15 Verenium Corp Enzyme mit alpha-amylase-aktivität und verfahren zu deren verwendung
ATE475707T1 (de) 2001-06-01 2010-08-15 Pgxhealth Llc Polymorphismen im menschlichen gen für cytochrom p450 polypeptid cyp2c8 und deren verwendung in diagnose undtherapie
EP1293576A1 (de) * 2001-09-18 2003-03-19 Integragen Zusammensetzungen und Verfahren zum Nachweis von Haplotypen
WO2003045227A2 (en) * 2001-11-28 2003-06-05 Dnaprint Genomics, Inc. Single nucleotide polymorphisms and combinations thereof predictive for paclitaxel responsiveness
AU2004229313B2 (en) 2003-03-06 2010-08-19 Basf Enzymes Llc Amylases, nucleic acids encoding them and methods for making and using them
MX2009006782A (es) 2006-12-21 2009-09-21 Verenium Corp Amilasas y glucoamilasas, acidos nucleicos que las codifican y metodos para formarlas y usarlas.
CA2916520A1 (en) * 2013-07-03 2015-01-08 Coyne Ip Holdings, Llc Methods for predicting responses to chemical or biologic substances

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309823B1 (en) * 1993-10-26 2001-10-30 Affymetrix, Inc. Arrays of nucleic acid probes for analyzing biotransformation genes and methods of using the same
CA2170052A1 (en) * 1994-07-06 1996-01-18 Takafumi Fukui Method of detecting human cytochrome p4501a2 gene polymorphism

Also Published As

Publication number Publication date
WO2000058508A3 (en) 2002-04-18
AU3448800A (en) 2000-10-16
EP1218537B1 (de) 2008-09-10
AU784761B2 (en) 2006-06-08
WO2000058508A2 (en) 2000-10-05
CA2363551A1 (en) 2000-10-05
DE60040231D1 (de) 2008-10-23
EP1218537A2 (de) 2002-07-03

Similar Documents

Publication Publication Date Title
WO2000047771A3 (en) Biallelic markers derived from genomic regions carrying genes involved in arachidonic acid metabolism
WO1999032644A3 (en) Prostate cancer gene
WO2001051659A3 (en) Biallelic markers derived from genomic regions carrying genes involved in central nervous system disorders
DE60041912D1 (de) Polymorphe marker des lsr-gens
ATE408025T1 (de) Biallelische marker die im zusammenhang stehen mit medikamentenmetabolismus beteiligten genen
WO1999054500A3 (en) Biallelic markers for use in constructing a high density disequilibrium map of the human genome
CA2348828A1 (en) Genomic and complete cdna sequences of apm1 and biallelic markers thereof
EP1069189A3 (de) Genotypisierung bialleler Marker
WO2002006525A3 (en) Obesity associated biallelic marker maps
WO2001079234A3 (en) Haplotypes of the apoe gene
WO2001079230A3 (en) Haplotypes of the ugt1a1 gene
WO2001027312A3 (en) Drug target isogenes: polymorphisms in the m1 muscarinic acetylcholine receptor gene
MXPA04004291A (es) Polimorfismos de un unico nucleotido en la gh-1.
WO2001011010A3 (en) Drug target isogenes: polymorphisms in the immunoglobulin e receptor i alpha subunit gene
WO2001079224A3 (en) Haplotypes of the cyp8b1 gene
WO2001027313A3 (en) Drug target isogenes: polymorphisms in the cholinergic receptor, muscarinic 2 gene
WO2001029176A3 (en) Drug target isogenes: polymorphisms in the cholinergic receptor, muscarinic 3 gene
WO2001079237A3 (en) Haplotypes of the galr1 gene
Szantai et al. Haplotyping of the deoxycytidine kinase gene by multicapillary electrophoresis
Hamilton Isolation and characterization of nuclear microsatellite loci in the tropical tree Corythophora alta (Lecythidaceae)
WO2001079240A3 (en) Haplotypes of the rangap1 gene
WO2001079238A3 (en) Haplotypes of the mmp3 gene
WO2001025194A3 (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1b gene
WO2002026766A3 (en) Haplotypes of the sstr4 gene
WO2001027311A3 (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1d gene

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties